Autologous T-cell vaccines materials and method

Details for Australian Patent Application No. 2002339914 (hide)

Owner Baylor College of Medicine Opexa Pharmaceuticals, Inc.

Inventors Zang, Jingwu Zhang

Agent Shelston IP

Pub. Number AU-B-2002339914

PCT Number PCT/US02/28874

PCT Pub. Number WO2003/024393

Priority 09/952,532 14.09.01 US

Filing date 12 September 2002

Wipo publication date 1 April 2003

Acceptance publication date 24 March 2005

International Classifications

A61K 039/00 Medicinal preparations containing antigens or antibodies

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 09/952,532 14.09.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002339914

24 February 2005 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Zang, Jingwu Zhang

24 March 2005 Application Accepted

  Published as AU-B-2002339914

21 July 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002339915-ELECTRONIC ACKNOWLEDGMENT OF RECEIPT OF INVENTORY

2002339913-STATE ESTIMATION AND SCHEDULING FOR A MANUFACTURING SYSTEM